Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes.
about
Sildenafil citrate increases myocardial cGMP content in rat heart, decreases its hypertrophic response to isoproterenol and decreases myocardial leak of creatine kinase and troponin TBreakthrough in heart failure with preserved ejection fraction: are we there yet?Interaction of Hydrogen Sulfide with Nitric Oxide in the Cardiovascular SystemCardiac endothelium-myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fractioncGMP Signals Modulate cAMP Levels in a Compartment-Specific Manner to Regulate Catecholamine-Dependent Signaling in Cardiac MyocytesNitric oxide regulates cardiac intracellular Na⁺ and Ca²⁺ by modulating Na/K ATPase via PKCε and phospholemman-dependent mechanismDisplacement-encoded and manganese-enhanced cardiac MRI reveal that nNOS, not eNOS, plays a dominant role in modulating contraction and calcium influx in the mammalian heart.NO/redox disequilibrium in the failing heart and cardiovascular system.PDE5A suppression of acute beta-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation.Role of phosphodiesterase-5 inhibitors in heart failure: emerging data and concepts.Pivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts.The protective effects of Polygonum multiflorum stilbeneglycoside preconditioning in an ischemia/reperfusion model of HUVECsNitric oxide: not just a negative inotrope.Nitric oxide synthase expression and function in embryonic and adult cardiomyocytes.Heart failure, oxidative stress, and ion channel modulation.Cyclic nucleotide phosphodiesterase PDE1C1 in human cardiac myocytes.Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.Abnormalities in arterial-ventricular coupling in older healthy persons are attenuated by sodium nitroprussidePositive inotropic and lusitropic effects of HNO/NO- in failing hearts: independence from beta-adrenergic signaling.Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity.Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice.An investigation of the effects of zaprinast, a PDE inhibitor, on the nitrergic control of the urethra in anaesthetized female rats.Mechanical and non-mechanical functions of Dystrophin can prevent cardiac abnormalities in Drosophila.Sildenafil preserves diastolic relaxation after reduction by L-NAME and increases phosphodiesterase-5 in the intercalated discs of cardiac myocytes and arteriolesOrthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: a novel redox paradigm.Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component?Exogenous intravascular nitric oxide enhances ventricular function after hemodilution with plasma expanderNitric oxide donor, NOC7, reveals dose dependently and cGMP pathway independently biphasic effects on contractile force of isolated rat heart after global ischemia.Nitric oxide signaling and the regulation of myocardial function.Dietary nitrate improves cardiac contractility via enhanced cellular Ca²⁺ signaling.Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate-salt hypertensionSildenafil reduces L-NAME-induced severe hypertension and worsening of myocardial ischaemia-reperfusion damage in the rat.Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes.Modulation of myocardial contraction by peroxynitriteInhibitors of cyclic nucleotide phosphodiesterase 3 and 5 as therapeutic agents in heart failure.Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling networkThe fork in the nitric oxide road: cyclic GMP or nitrosylation?Hydralazine and organic nitrates restore impaired excitation-contraction coupling by reducing calcium leak associated with nitroso-redox imbalanceVardenafil protects isolated rat hearts at reperfusion dependent on GC and PKGDeletion of inducible nitric oxide synthase provides cardioprotection in mice with 2-kidney, 1-clip hypertension.
P2860
Q24805251-EAE0A325-1A29-4734-A1BF-6407F1559D44Q26771999-E2FB35AF-E6CA-4456-AE41-1C0F4D958F02Q26774063-BC28A889-CB87-4C28-BE51-4F4B70796D24Q26853363-5884B207-BE49-4481-9AC1-54A2CB850225Q29306674-7A08689C-FC9F-4F05-B8ED-60CDCCD40DBFQ30413897-C99D3D98-793E-43A2-B2D3-DC3597EB011CQ30423062-BD0CFEC9-095E-4728-853D-18548500328CQ30475784-B16985F5-7A07-490A-87EA-0B690868C248Q30494729-BC6D2CCE-4112-4207-934E-9B69CB7C1E19Q30575578-A3900F3F-7702-49BD-98C0-64BB79073D71Q33552229-66223C32-0565-44E7-ABDC-14793D92B122Q33557191-CBA1109A-6A7B-4F04-A3D4-D23D9A17B6FBQ34398226-CC11FCCF-CD47-4FDA-AECA-44C5DC1BC408Q34465838-9AEA37E7-FCA2-4983-AD93-5F124EEE8B4CQ34667671-B496CB67-0B58-4E84-A578-2D452B99A8C6Q34668034-291B9E47-D3C0-4677-AF33-5342A9162C6CQ34892722-F32086D2-529B-4D07-AA84-684F13D1F023Q34979780-BD7218F9-8A90-4D6F-97CB-A60FBF99E09BQ34983537-99DF5A4B-B625-4E05-B093-EE1B0D029ACDQ35035923-C256A834-4E2E-433D-B6BD-8021E383FC2DQ35037549-D982EC58-5AD5-4497-B2F9-C03D4C4535B4Q35044398-C4D1777B-1966-4A4F-89AD-5236C58E5D13Q35122156-7442D0FD-E6FB-4F0E-B306-9C9FA0658EF8Q35141990-7C8831EC-E89E-4A26-999C-244BF4F39049Q35175535-14BB53FB-BCF4-412B-B6D6-7F86F353EC30Q35213988-29EDBD2B-AA9C-4A63-9FF7-84B797E72221Q35634178-0040F460-04C9-4CDC-B750-40018F5ACDA8Q35741041-0F6CC9FD-E313-4365-A2AF-437AEBFE1175Q35765975-D9DC9D66-6D62-4510-A9B8-0F1BFF819F0CQ35987513-0FD5C8B4-BA3D-4E06-95F2-0FC27516D04DQ36148204-112C96B2-2AD2-41C7-AAF1-F5F8AEBF338AQ36357886-206F1E91-554F-4D9E-9E7D-57B744668875Q36368961-DA35BB25-DCF1-4BCA-AAA3-AA54DEF446DEQ36461910-A767EDE3-0E96-4B51-86F8-FF97B5B4BA60Q36512551-FE228B11-ED55-4705-91D7-659032EF31FDQ36609843-4C49E2FB-8014-41B2-9676-17A00B130FF6Q36630990-6F5FCD60-402B-4015-81A8-E2F2AE193224Q36647370-B58A0DAE-0901-4800-B454-8553F4C427C9Q36735813-CCDF25B7-4DA1-427C-A94B-B6E102823C1EQ37085195-1E62C71E-31CE-47DD-8234-840209B3A98B
P2860
Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Activation of distinct cAMP-de ...... ric oxide in cardiac myocytes.
@en
Activation of distinct cAMP-de ...... ric oxide in cardiac myocytes.
@nl
type
label
Activation of distinct cAMP-de ...... ric oxide in cardiac myocytes.
@en
Activation of distinct cAMP-de ...... ric oxide in cardiac myocytes.
@nl
prefLabel
Activation of distinct cAMP-de ...... ric oxide in cardiac myocytes.
@en
Activation of distinct cAMP-de ...... ric oxide in cardiac myocytes.
@nl
P2093
P356
P1433
P1476
Activation of distinct cAMP-de ...... ric oxide in cardiac myocytes.
@en
P2093
Lakatta EG
Sollott SJ
Vila-Petroff MG
P304
P356
10.1161/01.RES.84.9.1020
P577
1999-05-01T00:00:00Z